Cor Vasa 2018, 60(5):e448-e451 | DOI: 10.1016/j.crvasa.2017.06.010
Iatrogenic life-threatening condition in a patient with multiple rare disorders
- a Department of Cardiology and Hypertension, Central Research Hospital, The Ministry of the Interior, Wołoska 137, 02-507 Warsaw, Mazovia, Poland
- b Department of Cardiac Surgery, Central Research Hospital, The Ministry of the Interior, Wołoska 137, 02-507 Warsaw, Mazovia, Poland
- c Faculty of Health Sciences, Pulaski University, Malczewskiego 29, 26-600 Radom, Mazovia, Poland
- d Department of Applied Physiology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Mazovia, Poland
Andersen-Tawil syndrome (long QT syndrome 7) is a rare inherited disorder, characterized by periodic paralysis, long QT, ventricular arrhythmias and skeletal abnormalities.
A 52-year-old female with a history of long QT syndrome, ICD implantation (secondary prevention of cardiac arrest) and systemic vasculitis was admitted due to an electrical storm caused by endocarditis. She was admitted again short after discharge due to multi-organ failure, which was caused probably by withdrawal of steroids and VKA. Characteristic dysmorphic features resulted in Andersen-Tawil syndrome suspicion.
If patients have one rare disorder they should not be excluded from further diagnostics, and very detailed outpatient care.
Keywords: Andersen-Tawil syndrome; Anticoagulant treatment; Congenital disease; Infectious endocarditis; Long QT syndrome; Multi-organ failure; Valve replacement
Received: January 28, 2017; Revised: June 19, 2017; Accepted: June 21, 2017; Published: October 1, 2018 Show citation
References
- P.J. Schwartz, A.J. Moss, G.M. Vincent, et al., Diagnostic criteria for the long QT syndrome. An update, Circulation 88 (1993) 782-784.
Go to original source...
Go to PubMed...
- M. Tristani-Firouzi, J.L. Jensen, M.R. Donaldson, et al., Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome), Journal of Clinical Investigation 110 (2002) 381-388.
Go to original source...
Go to PubMed...
- L. Zhang, D.W. Benson, M. Tristani-Firouzi, et al., Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype, Circulation 111 (2005) 2720-2726.
Go to original source...
Go to PubMed...
- M.R. Donaldson, J.L. Jensen, M. Tristani-Firouzi, et al., PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome, Neurology 60 (2003) 1811-1816.
Go to original source...
Go to PubMed...
- M. Brignole, A. Auricchio, G. Baron-Esquivias, et al., 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA), European Heart Journal 34 (2013) 2281-2329.
Go to original source...
- D.Z. Uslan, M.R. Sohail, J.L. St Sauver, et al., Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study, Archives of Internal Medicine 167 (2007) 669-675.
Go to original source...
Go to PubMed...
- E. Athan, V.H. Chu, P. Tattevin, et al., Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices, Journal of the American Medical Association 307 (2012) 1727-1735.
Go to original source...
Go to PubMed...
- S. Kato, K. Takahashi, K. Ayabe, et al., Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients, British Journal of Haematology 154 (2011) 373-377.
Go to original source...
Go to PubMed...